Recently, when The Dr. Oz Show’s Dr. Mehmet Oz turned to his television audience to ask if anyone had heard of transcranial magnetic stimulation (TMS) after a demonstration of its effectiveness in treatment-resistant depression (TRD), no one in the audience raised their hands.
I wonder why Drs. Desseilles, Fava, Mischoulon, and Freeman did not discuss TMS as an important choice for TRD in their article (“Personalizing depression treatment: 2 clinical tools,” Current Psychiatry, March 2012, p. 26-33). Harvard Medical School has done trials of TMS and McLean Hospital has created a positive video on TMS.
Andrew Krompier, MD
Private Practice
San Ramon, CA